ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,172.15
0.63%
Dow Jones
38,225.66
0.85%
Gold vs US Dollar
2,303.125
-0.91%
Brent Oil
83.63
0.11%
Bitcoin
59,141.90
1.55%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Femasys Inc (FEMY)

  7. Femasys Inc (FEMY) News

Femasys (FEMY)

Femasys Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FEMY
DateTimeSourceHeadlineSymbolCompany
18/04/202413:30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
28/03/202420:05GlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
21/03/202413:00GlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
20/03/202412:15GlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
13/03/202413:00GlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
06/03/202414:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/03/202414:00GlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
28/02/202414:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
14/02/202402:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
14/02/202402:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
06/02/202413:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
02/02/202421:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/02/202421:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/02/202421:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
08/12/202314:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
30/11/202322:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
29/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
22/11/202321:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
22/11/202321:33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
22/11/202321:12Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
21/11/202322:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
15/11/202322:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
15/11/202313:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
02/11/202301:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/10/202313:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
03/10/202314:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
03/10/202314:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
27/09/202313:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/09/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY

Your Recent History

LSE
TERN
Tern
LSE
SCE
Surface Transforms
LSE
BIRD
Blackbird
LSE
AAU
Ariana Resources
LSE
IES
Invinity Energy Systems
LSE
SOLG
Solgold
LSE
SCLP
Scancell
LSE
POS
Plexus
LSE
SYME
Supply@me Capital
LSE
GKP
Gulf Keystone Petroleum
LSE
GFM
Griffin Mining
LSE
LLOY
Lloyds Banking
LSE
AAZ
Anglo Asian Mining
LSE
BT.A
Bt
LSE
PANR
Pantheon Resources
LSE
I3E
I3 Energy
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved